The Valley Desk

NCT06376162 · Interventional trial

Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia

Overall registry status Recruiting

Phase 1

Conditions Relapsed/Refractory KMT2A-r Acute Leukemia, Relapsed/Refractory NPM1-m Acute Leukemia, Relapsed/Refractory NUP98-r Acute Leukemia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov